SinoMab Bioscience Ltd. (3681) Financial Statements

1 Followers

SinoMab Bioscience Ltd. Financial Overview

SinoMab Bioscience Ltd.'s market cap is currently HK$1.82B. The company's EPS TTM is HK$-0.0896; its P/E ratio is -7.60; SinoMab Bioscience Ltd. is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 0.00	¥ 2.03M	¥ 1.36M	¥ 4.03M	¥ 26.66M
Gross Profit	¥ 0.00	¥ 543.00K	¥ 422.00K	¥ 4.03M	¥ 26.66M
Operating Income	¥ -124.70M	¥ -161.35M	¥ -229.57M	¥ -258.93M	¥ -305.86M
EBITDA	¥ -124.70M	¥ -142.79M	¥ -200.46M	¥ -244.29M	¥ -296.43M
Net Income	¥ -102.27M	¥ -185.14M	¥ -243.11M	¥ -284.16M	¥ -288.19M
Balance Sheet
Cash & Short-Term Investments	¥ 382.40M	¥ 106.88M	¥ 234.66M	¥ 376.19M	¥ 589.53M
Total Assets	¥ 908.50M	¥ 753.10M	¥ 847.79M	¥ 1.01B	¥ 1.04B
Total Debt	¥ 338.64M	¥ 482.27M	¥ 450.81M	¥ 357.18M	¥ 275.46M
Net Debt	¥ 4.97M	¥ 420.37M	¥ 247.14M	¥ 11.47M	¥ -287.52M
Total Liabilities	¥ 400.41M	¥ 560.19M	¥ 552.20M	¥ 498.77M	¥ 361.43M
Stockholders' Equity	¥ 508.10M	¥ 192.91M	¥ 295.58M	¥ 509.57M	¥ 680.23M
Cash Flow
Free Cash Flow	¥ -95.78M	¥ -172.30M	¥ -237.74M	¥ -413.29M	¥ -345.30M
Operating Cash Flow	¥ -70.48M	¥ -130.80M	¥ -133.85M	¥ -300.54M	¥ -147.06M
Investing Cash Flow	¥ 16.25M	¥ -94.48M	¥ -96.92M	¥ -81.36M	¥ -137.70M
Financing Cash Flow	¥ 329.39M	¥ 73.27M	¥ 82.27M	¥ 102.28M	¥ 57.52M

Currency in CNY

SinoMab Bioscience Ltd. Earnings and Revenue History

Income Statement >

SinoMab Bioscience Ltd. Debt to Assets

Balance Sheet >

SinoMab Bioscience Ltd. Cash Flow

Cash Flow >

SinoMab Bioscience Ltd. Forecast EPS vs Actual EPS

Earnings >